Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEthic Inc.
Latest Disclosed Ownership85,798 shares
Latest Disclosed Value $ 11,957,714
Ethic Inc. reports 7.09% increase in ownership of GILD / Gilead Sciences, Inc.

On April 27, 2026 - Ethic Inc. filed a 13F-HR form disclosing ownership of 85,798 shares of Gilead Sciences, Inc. (CH:GILD) valued at $11,957,714 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 80,119 shares of Gilead Sciences, Inc.. This represents a change in shares of 7.09% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F GILEAD SCIENCES COM 375558103 85,798 5,679 7.09 11,958 21.60 0.1873
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 80,119 3,103 4.03 9,834 15.03 0.1512
2025-10-17 2025-09-30 13F GILEAD SCIENCES COM 375558103 77,016 1,923 2.56 8,549 2.86 0.1407
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 75,093 3,821 5.36 8,311 4.78 0.1488
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 71,272 -33,372 -31.89 7,931 -17.94 0.1607
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 104,644 7,638 7.87 9,666 36.03 0.1950
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 97,006 7,482 8.36 7,106 15.68 0.1795
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 89,524 -7,482 -7.71 6,142 -13.55 0.1440
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 97,006 -15,772 -13.98 7,106 -22.23 0.1795
2024-02-14 2023-12-31 13F GILEAD SCIENCES COM 375558103 112,778 4,423 4.08 9,136 12.51 0.2702
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 108,355 7,508 7.44 8,120 4.48 0.2849
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 100,847 5,808 6.11 7,772 -1.43 0.2882
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 95,039 31,117 48.68 7,885 43.70 0.3199
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 63,922 19,028 42.38 5,488 98.16 0.2965
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 44,894 13,979 45.22 2,769 44.90 0.1880
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 30,915 3,895 14.42 1,911 18.99 0.1332
2022-05-16 2022-03-31 13F GILEAD SCIENCES COM 375558103 27,020 -3,626 -11.83 1,606 -27.82 0.1109
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 30,646 -12,477 -28.93 2,225 -26.13 0.1715
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 43,123 -6,690 -13.43 3,012 -12.19 0.3083
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 49,813 15,969 47.18 3,430 56.84 0.4158
2021-05-13 2021-03-31 13F GILEAD SCIENCES COM 375558103 33,844 14,567 75.57 2,187 94.75 0.3898
2021-02-10 2020-12-31 13F GILEAD SCIENCES COM 375558103 19,277 4,419 29.74 1,123 19.60 0.2969
2020-10-27 2020-09-30 13F GILEAD SCIENCES COM 375558103 14,858 3,772 34.02 939 10.08 0.3591
2020-08-12 2020-06-30 13F GILEAD SCIENCES COM 375558103 11,086 1,446 15.00 853 18.31 0.4854
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 9,640 1,878 24.19 721 43.06 0.6020
2020-05-22 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 7,762 7,762 504 0.3843
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 7,746 503 0.4335
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.